Covid-19 Impact on Minimally Invasive Neurosurgery Device Market, Global Research Reports 2020-2021

2 Global Minimally Invasive Neurosurgery Device Quarterly Market Size Analysis

• 2.1 Minimally Invasive Neurosurgery Device Business Impact Assessment - COVID-19
  • 2.1.1 Global Minimally Invasive Neurosurgery Device Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Minimally Invasive Neurosurgery Device Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Minimally Invasive Neurosurgery Device Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Minimally Invasive Neurosurgery Device Headquarters and Area Served
• 3.3 Date of Key Players Enter into Minimally Invasive Neurosurgery Device Market
• 3.4 Key Players Minimally Invasive Neurosurgery Device Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Minimally Invasive Neurosurgery Device Segments, By Type

• 4.1 Introduction
  • 1.4.1 Surgical Devices
  • 1.4.2 Monitoring & Visualization Devices
  • 1.4.3 Endoscopy Devices
• 4.2 By Type, Global Minimally Invasive Neurosurgery Device Market Size, 2019-2021

5 Impact of Covid-19 on Minimally Invasive Neurosurgery Device Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospitals
  • 5.5.2 Clinics
  • 5.5.3 Ambulatory Surgical Centers
• 5.2 By Application, Global Minimally Invasive Neurosurgery Device Market Size, 2019-2021
  • 5.2.1 By Application, Global Minimally Invasive Neurosurgery Device Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Karl Storz
  • 7.1.1 Karl Storz Business Overview
  • 7.1.2 Karl Storz Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.1.3 Karl Storz Minimally Invasive Neurosurgery Device Product Introduction
  • 7.1.4 Karl Storz Response to COVID-19 and Related Developments
• 7.2 NICO
  • 7.2.1 NICO Business Overview
  • 7.2.2 NICO Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.2.3 NICO Minimally Invasive Neurosurgery Device Product Introduction
  • 7.2.4 NICO Response to COVID-19 and Related Developments
• 7.3 Olympus Corporation
  • 7.3.1 Olympus Corporation Business Overview
  • 7.3.2 Olympus Corporation Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.3.3 Olympus Corporation Minimally Invasive Neurosurgery Device Product Introduction
  • 7.3.4 Olympus Corporation Response to COVID-19 and Related Developments
• 7.4 Medtronic
  • 7.4.1 Medtronic Business Overview
  • 7.4.2 Medtronic Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.4.3 Medtronic Minimally Invasive Neurosurgery Device Product Introduction
  • 7.4.4 Medtronic Response to COVID-19 and Related Developments
• 7.5 Conmed Corporation
  • 7.5.1 Conmed Corporation Business Overview
  • 7.5.2 Conmed Corporation Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.5.3 Conmed Corporation Minimally Invasive Neurosurgery Device Product Introduction
  • 7.5.4 Conmed Corporation Response to COVID-19 and Related Developments
• 7.6 Smith & Nephew
  • 7.6.1 Smith & Nephew Business Overview
  • 7.6.2 Smith & Nephew Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.6.3 Smith & Nephew Minimally Invasive Neurosurgery Device Product Introduction
  • 7.6.4 Smith & Nephew Response to COVID-19 and Related Developments
• 7.7 Abbott Laboratories
  • 7.7.1 Abbott Laboratories Business Overview
  • 7.7.2 Abbott Laboratories Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.7.3 Abbott Laboratories Minimally Invasive Neurosurgery Device Product Introduction
  • 7.7.4 Abbott Laboratories Response to COVID-19 and Related Developments
• 7.8 GE Healthcare
  • 7.8.1 GE Healthcare Business Overview
  • 7.8.2 GE Healthcare Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.8.3 GE Healthcare Minimally Invasive Neurosurgery Device Product Introduction
  • 7.8.4 GE Healthcare Response to COVID-19 and Related Developments
• 7.9 NuVasive
  • 7.9.1 NuVasive Business Overview
  • 7.9.2 NuVasive Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.9.3 NuVasive Minimally Invasive Neurosurgery Device Product Introduction
  • 7.9.4 NuVasive Response to COVID-19 and Related Developments
• 7.10 Smith & Nephew
  • 7.10.1 Smith & Nephew Business Overview
  • 7.10.2 Smith & Nephew Minimally Invasive Neurosurgery Device Quarterly Revenue, 2020
  • 7.10.3 Smith & Nephew Minimally Invasive Neurosurgery Device Product Introduction
  • 7.10.4 Smith & Nephew Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US